The 5th Annual Nordic-American
Life Science Conference

NALS CONFERENCE IMPORTANT DATES:

Meet emerging and small-cap companies with meaningful approaching inflection points:

Emerging BioPharma Day
OCTOBER 22, 2020

Emerging MedTech Day
NOVEMBER 12, 2020

Listed Nordic public companies and pre-ASH panel discussion:

Global Markets Day
DECEMBER 3, 2020

FOR MORE INFORMATION PLEASE CONNECT WITH US

Celebrating Nordic-American Life Science Investment and Partnering

Welcome to the Fifth Annual Nordic-American Life Science Conference. This uniquely Nordic-US virtual experience connects global investors with Nordic life science advancements and provides insight into the Nordic companies breaking new ground in BioPharma and MedTech. 

Through a partnership with DNB, Nasdaq, and Business Sweden, together with Back Bay Life Science Advisors, the NALS Conference brings together dozens of high-caliber private and publicly-listed Nordic healthcare companies and other industry leaders in a three-day virtual event.

Join life science and banking experts, and distinguished partners to learn about advances in oncology, rare diseases, neurology, diagnostic imaging, and many other therapeutic areas. 

REGISTER TODAY: Registration is complimentary for qualified investors and BD executives, but seats are limited. Reserve your place today the Nordic-American Life Science Conference 2020.

  • Insight into the best of Nordic investment opportunities.

  • Expert insights for corporate and investor communities into the thriving Nordic life science ecosystems.

  • Participation by institutional investors, prominent public companies, partners, DNB research analysts, bankers, and Back Bay strategists. 

  • Discussion of global drivers and development in Nordic geographies.

  • Connections to Nordic life science clusters and industry representatives.

.

NALS Conference Program

EMERGING BIOPHARMA DAY (October 22, 8:00 AM EST)

  • Emerging BioPharma company presentations by OxThera, Immedica, Lokon Pharma, NMD Pharma, F2G, Saniona, Oncoinvent, and Zelluna Immunotherapy.

  • Fireside Chat - The BioInnovation Institute (BII), a Novo Nordisk Foundation initiative, is one of the vital engines of early-stage growth in the Nordics and beyond. Join a fireside chat with BII and Back Bay on the many promising offerings of the Nordic ecosystem, the gravitational pull produced by BII, and how BII initiatives and structure encourage companies' growth from academia through public emergence and beyond.

  • Expert Panel Discussion: Preparing Nordic BioPharma to Serve on a Global Scale, with experts from Hadean Ventures, Lundbeckfonden Ventures, Janssen Pharmaceuticals, Back Bay Life Science Advisors, Nasdaq, and Kompassi GmbH.

EMERGING MEDTECH DAY (November 12, 2020, 8:00 AM EST)

  • Emerging MedTech company presentations by Palette Life Sciences, Medtentia, MedTrace Pharma, Reapplix, SonoClear, EpiGuard and more.

  • Expert Panel Discussion: The Acceleration of MedTech in the post-Covid era with experts from Ambu, Back Bay Life Science Advisors, and international banking and life science experts.

 GLOBAL MARKETS DAY (December 3, 2020, 8:00 AM EST)

  • Listed company presentations with Vitrolife, Getinge, Sobi, Oncopeptides, Ossur, followed by a pre-ASH panel discussion.

 

REGISTER FOR THE THREE-PART EVENT

PARTNERS

TOGETHER WITH

 
 

SPECIAL THANKS TO OUR CONTRIBUTORS

Click on logo to read more about each company >